Drugs in Context

📣 New article in @drugsincontext Real-world use of a hydrophilic curcumin-based oral formulation in the management of macular oedema: a collection of clinical experiences Allegrini et al. #ophthalmology #MacularEdema #curcumin #RealWorldData drugsincontext.com/real-world-use…

📣 New in @drugsincontext Upadacitinib for the treatment of radiographic axial spondyloarthritis — case series and review of the literature Lopalco et al. #drugsincontext #rheumatology #JAKinhibitors #pharmacology drugsincontext.com/upadacitinib-f…

📣 New in @drugsincontext Patterns of treatment and outcomes of patients with metastatic HER2-low #breastcancer treated with CDK4/6 inhibitors and #hormonetherapy Sottotetti et al. #drugsincontext #oncology #metastaticbreastcancer #realworldstudy drugsincontext.com/patterns-of-tr…

📣New article in @drugsincontext Switching from multiple-inhaler triple therapy to single, extra fine-inhaler triple therapy in severe refractory #asthma with EGPA: beyond control. Case report and review of the literature Menzella et al. drugsincontext.com/switching-from…

📢 New Editorial in @DrugsinContext by our Associate Editor Rajesh Tampi Lecanemab for mild Alzheimer disease – is there a way forward? drugsincontext.com/lecanemab-for-… #drugsincontext #alzheimers #geriatrics #psychiatry #pharmacology #EuropeanMedicinesAgency #lecanemab

📣 New article published in @drugsincontext Is carvedilol superior to propranolol in patients with #cirrhosis with #portalhypertension: a systematic and meta-analysis Rajpurohit et al. #gastroenterology #hepatology #pharmacology drugsincontext.com/is-carvedilol-…

New article in @drugsincontext Obinutuzumab in membranous nephropathy: a potential game-changer in treatment Sessa et al. #drugsincontext #nephrology #pharmacology #monoclonalantibodies #clinicaldata #drugefficacy drugsincontext.com/obinutuzumab-i…

New in @drugsincontext Real-life effectiveness of FLOT in resectable gastric cancer: existing challenges Serra et al. #drugsincontext #oncology #gastriccancer #nutritionalstatus #chemotherapy #gastroenterology #RealWorldEvidence drugsincontext.com/real-life-effe…

New in @drugsincontext Clinical remission and control in severe #asthma: agreements and disagreements Bosi et al. #drugsincontext #severeasthma #respiratorydisease #immunology #allergiology #allergies #inflammation #oralcorticosteroids drugsincontext.com/clinical-remis…

New in @drugsincontext Rapid Efficacy of riSankizumab in pretibial psoriasis invOLVEment: RESOLVE Bernardini et al. drugsincontext.com/rapid-efficacy… #drugsincontext #dermatology #psoriasis #mabs #qualityoflife #skin

New in @drugsincontext RNA interference therapy in #cardiology: will new targets improve therapeutic goals? Fazoli et al. #drugsincontext #pharmacology #RNAdrugs drugsincontext.com/rna-interferen…

New in @drugsincontext Risk of gastrointestinal bleeding in Asian patients receiving oral anticoagulants for stroke prevention in atrial fibrillation Bimbo Diaz et al. #drugsincontext #stroke #anticoagulants #cardiology #atrialfibrillation drugsincontext.com/risk-of-gastro…

New in @drugsincontext A UK multicentre audit of the management of patients with primary #hypercholesterolaemia or mixed #dyslipidaemia with bempedoic acid against published lipid-lowering treatment targets Ramachandran et al. #cardiology drugsincontext.com/a-uk-multicent…

New in @drugsincontext Sublingually administered bacterial lysates: rationale, mechanisms of action and clinical outcomes Braido et al. #drugsincontext #respiratorymedicine #immunology #prophylaxis drugsincontext.com/sublingually-a…

New in @drugsincontext Towards full recovery with lurasidone: effective doses in the treatment of agitation, affective, positive and cognitive symptoms in schizophrenia, and dual psychosis Guarro Carreras et al. #schizophrenia #psychiatry #pharmacology drugsincontext.com/towards-full-r…

New in @DrugsinContext New and emerging oral therapies for psoriasis Yilmaz et al. #drugsincontext #dermatology #psoriasis #therapies #emergingtreatments #pharmacology drugsincontext.com/new-and-emergi…

New in @drugsincontext Anti-IL-17 monoclonal antibodies and bullous pemphigoid: treatment or causal agents? A case series and review of the literature Lugli et al. #drugsincontext #dermatology #mabs #IL17 #treatment #pharmacology drugsincontext.com/anti-il-17-mon…

New in @drugsincontext Antibiotic-induced neuropsychiatric toxicity: epidemiology, mechanisms and management strategies – a narrative literature review Althubyani et al. #antibiotics #neuropsychiatry #neurotoxicity #pharmacology #infectiousdisease drugsincontext.com/antibiotic-ind…

New article in @DrugsinContext Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case series Lombardi et al. #drugsincontext #asthma #corticosteroids #respiratorydisease #monoclonalantibody drugsincontext.com/very-long-term…

New in @drugsincontext Nivolumab plus ipilimumab with chemotherapy in metastatic NSCLC: minireview and a case study of a patient negative for PD-L1 Alessandro Morabito #oncology #immunecheckpoints #nsclc #lungcancer #pdl1 #chemotherapy #pharmacology drugsincontext.com/nivolumab-plus…